Hanmi Pharm 2 innovative new drugs for rare disease treatment… FDA approval for Phase 2 clinical trial
Hanmi Pharm received FDA approval for Phase 2 clinical trials of two new drug candidates for rare diseases
The US FDA approves Phase 2 clinical trials of two innovative new drugs for rare disease treatment by Hanmi Pharmaceutical
Hanmi Pharm unveils its global R&D strategy… “Expectation of two new drugs to be approved by the US FDA within this year”
